ReviewNPJ precision oncology2021

Selective KRAS G12C inhibitors in non-small cell lung cancer: chemistry, concurrent pathway alterations, and clinical outcomes.

Gabriela Palma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.